Early blockade of S1P2, inhibition of Notch3, silencing of STAT3, miRNA-135b, or YAP all attenuate S1P-induced proliferation and vascular remodeling of PASMCs, thus preventing the development of PAH [150]. The gene discussed is S1PR2; the disease is pulmonary arterial hypertension.